Menu

  • Cardiac Ablation & Mapping
  • Ablation Therapies
  • Clinical Evidence
  • Resources

    • Safe, simple, and effective AF ablation procedures

    The Arctic Front™ cryoablation system is the leader in cryoballoon technology with over 17 years of clinical experience, treating more than one million patients worldwide.1

    Arctic Front Advance™ and Arctic Front Advance Pro™ enable safe effective, and efficient procedures. The Arctic Front™ system provides physicians with a straightforward approach to PVI with minimal applications, durable lesions, and delivering consistent and predictable results,2 for first-line, paroxysmal, and persistent AF patients.3–6

     

    Arctic Front™ benefits

    • High PVI occlusion rates with single-shot freeze7–9
    • Uniform ice cap homogeneity and continuous lesion formation10
    • Strong safety profile with low rates of serious adverse events11
    • Consistent and predicable procedure outcomes2

    The Medtronic cryoablation system includes the Freezor™ family of cryoablation catheters, which include devices approved for the treatment of AF or pediatric and adult AVNRT.12,13

    Watch the video to see how the Arctic Front™ cryoballoon system works.

    Strong outcomes in persistent AF across various centres

    Freedom from AF can be achieved for 54–82% of patients suffering from persistent AF following an index Medtronic cryoballoon procedure.

    Consistent result in paroxysmal AF across various centers

    Arctic Front Advance™ cryoballoon single-center published studies demonstrating single-procedure freedom from AF, AT, and AFL at 12 months.

    Arrhythmia monitoring methods and definition of success (freedom from AF only or AF/AT/AFL) varied between studies.

    Early rhythm control with Arctic Front™ cryoballoon

    The Medtronic Arctic Front™ cryoballoon system is the only ablation system FDA-approved as an initial rhythm control strategy for patients with paroxysmal atrial fibrillation. It is also indicated for the treatment of paroxysmal and persistent† AF patients.

    Meta-analysis of three randomized first-line trials, STOP AF First, EARLY-AF, and Cryo-FIRST, demonstrates cryoablation is more effective than antiarrhythmic drugs as an initial first-line therapy for patients with paroxysmal AF.​27

    • 74.6% freedom from atrial arrhythmia recurrence in the cryoballoon arm, versus
    • 45% in the antiarrhythmic drug arm
    • 39% relative reduction in the risk of atrial arrhythmia recurrence1
    • 8.32 points larger improvement in AFEQT score on average1
    • 29% relative reduction in healthcare utilization1
    • 62% relative reduction in hospitalization1
    See clinical trials

    The 1STOP Initiative

    1STOP (One Shot to PVI) is a large-scale, real-world data initiative capturing clinical insights from over 8'500 patients across more than 47 hospitals in Italy. It focuses on patients undergoing cardiac ablation using Medtronic’s Cardiac Ablation Solutions, including the Arctic Front™ family of cryoablation catheters and, more recently, the PulseSelect™ pulsed field ablation (PFA) system, and the Affera™ Mapping and Ablation system.​

    The initiative is designed to improve patient outcomes by collecting, managing, analyzing, and reporting treatment data - sometimes supported through the dedicated patient app, MyCryo App.​ To date, 1STOP has supported over 20 scientific publications, exploring key topics such as:​

    • Acute outcomes, procedural efficiency, and safety of pulsed field ablation (PFA)​

    • Learning curve and clinical adoption of the PulseSelect™ PFA system​​

    • Comparative performance of cryoballoon generations​​

    • Cryoablation outcomes across diverse patient risk profiles​​

    • Cryoablation by indication: first-line, redo, persistent, and paroxysmal AF​​

    • Early intervention strategies​​

    • Techniques to optimize patient outcomes​​

    • Imaging and time-to-isolation measurements​​

    Same day discharge

    Reduce the patient length of stay and shorten your AF ablation waiting list​.

    Discharging cryoablation patients on the same day has helped Hospitals and clinics reduce their waiting lists for ablations and, as a result, treat more AF patients.​

    Driving outpatient cryoablation procedures with Arctic Front™ Advance Pro™ has enabled the EP team at the University Hospital Center Montpellier in France to optimize hospital workflow while improving the overall patient experience.

    Watch Dr Javier Jimenez-Candil explain how discharging cryoablation patients on the same day has helped the University Hospital of Salamanca reduce their waiting lists for ablations and, as a result, treat more AF patients.

    Streamline your procedures

    Nitron CryoConsole™ Cardiac Cryoablation System

    • Sterile field operation and quicker reactivity with remote control​
    • Visualization of previous freeze in same location​

    PulseSelect™ PFA System
     

    • 0.7% primary safety event rate.28-29 
    • Unique safety features including R-wave gating and phrenic nerve test pulse​

    FlexCath Contour™ Steerable Sheath

    • Shorter tip length option for easier access to RIPV
    • 39% greater support during PV occlusion30

    FlexCath Cross™ Transseptal Solution

    • Zero exchange workflow
    • 16.6% reduction in total procedure time*31 *vs. NRG™ transseptal needle

    Educational resources on Medtronic Academy

    Access detailed product information, including specification sheets, videos, and presentations.

    Visit Medtronic Academy (open in new window)

    Related products